Tatsumi Can’t Meet High Japan Demand For Losartan Generic
This article was originally published in PharmAsia News
Executive Summary
Tatsumi Chemicals in Japan has requested relevant parties to refrain from giving out new prescriptions and to stop dispensing the generic ARB losartan potassium tablet TCK due to a supply shortage of the original drug substance.